20.592 articles found

The Expanding Role of Non-Coding RNAs in Neurodegenerative Diseases: From Biomarkers to Therapeutic Targets.

Zhao X, Zheng Y, Cai X, Yao Y, Qin D.

Pharmaceuticals (Basel) · 2026-01-03

DOI: 10.3390/ph19010092PMID: 41599691

Nose to Brain Delivery of Curcumin Loaded Therapeutic Nanostructures for Neurodegenerative Diseases.

Kalita R, Sarma A, Baruah H, Zaman A, Goswami D.

Biopharm Drug Dispos · 2026-01-03

DOI: 10.1002/bdd.70021PMID: 41482856

Effect of vestibular rehabilitation therapy on balance function and quality of life in patients with Parkinson's disease: a systematic review and meta-analysis.

Huang L, Bian T, Zhang Y, Zhang J, Jiang J, Gao N.

Neurol Sci · 2026-01-02

DOI: 10.1007/s10072-025-08670-1PMID: 41483334

A Comprehensive Review of Naringin Loaded Nano Drug Delivery System in Treatment of CNS Disorders.

Verma R, Bahadur S.

Curr Pharm Des · 2026-01-02

DOI: 10.2174/0113816128407188251116030341PMID: 41487012

Mesenchymal stem cell membrane camouflaged mesoporous polydopamine for Parkinson's disease treatment via alleviating oxidative stress mediated neuroinflammation

Chen Y, Lv W, Xu J, Li S, Song K, Gong Y, Zhao W, Liu H, Ding Z, Liu L, Yin J, Su D, Lu M, Fang X, Xin H.

Biomaterials · 2026-01-01

Correction: Unveiling the biochemical potential of Acacia jacquemontii as a therapeutic agent in parkinson’s disease: A multi-model in Vitro, In Vivo, and In Silico Study

Check source for author details

PloS one · 2026-01-01

Neuroprotective effects of empagliflozin and metformin combined therapy on rotenone induced Parkinsonism in Wistar rats via PI3K and PPARγ modulation

Mona M, Borg H, Ahmed A, Abass S, El-Kholy S.

Scientific reports · 2026-01-01

Efficacy and Safety of Safinamide as an Adjunct to Levodopa for Motor Fluctuations in Parkinson’s Disease: A Systematic Review and Meta‐Analysis of Randomized Controlled Trials

Ahmed A, Ahmed O, Dishean A, Gilbert C, Elkheir M, Sota H, Abdulaziz M, Mahmoud E, Ahmed R.

Parkinson's disease · 2026-01-01

Adult-Onset Levodopa-Unresponsive Parkinsonism as the Presenting Feature of Aromatic L-Amino Acid Decarboxylase Deficiency

Spiteri M, Tilney R, Said E, Vella M.

European journal of case reports in internal medicine · 2026-01-01

Therapeutic and Diagnostic Implications of Carbon Dot: An Advancement in the Avenue towards Cancer, Diabetes and Neurodegenerative Disorders.

Manna S, Banerjee S, De A, Banerjee S, Das S, Rakshit P, S K AK, Sen KK, De S.

Pharm Nanotechnol · 2026-01-01

DOI: 10.2174/0122117385314533240824090949PMID: 39350419

Navigating into the Paradigm of Nose-to-brain Delivery of Nanotherapeutics and their Repurposing as Nanotheranostics for Neurodegenerative Diseases.

Ali A, Emad NA, Sultana N, Waheed A, Aqil M, Sultana Y, Mujeeb M.

CNS Neurol Disord Drug Targets · 2026-01-01

DOI: 10.2174/0118715273319597240927044906PMID: 39400020

Parkinson's Disease: A Progressive Neurodegenerative Disorder and Structure-Activity Relationship of MAO Inhibitor Scaffolds as an Important Therapeutic Regimen.

Salauddin, Zaidi SAA, Ubaid M, Shamim S, Naim MJ, Khanna S, Alam O.

CNS Neurol Disord Drug Targets · 2026-01-01

DOI: 10.2174/0118715273324300241010054029PMID: 39482908